Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION
Report ID | 225852 |
Drug Identification Number | 02327813 |
Brand name | GALLIUM (GA67) CITRATE INJECTION |
Common or Proper name | Gallium (Ga 67) Citrate injection |
Company Name | CURIUM CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GALLIUM CITRATE GA 67 |
Strength(s) | 74MBq |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10ml |
ATC code | V09HX |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-04-21 |
Actual start date | 2024-04-21 |
Estimated end date | 2024-04-28 |
Actual end date | 2024-04-28 |
Shortage status | Resolved |
Updated date | 2024-04-29 |
Company comments | Due to lower than anticipated yields of Ga-67 raw material, we are unable to meet total market demand for Gallium Citrate Ga 67 Injection shipping Apr 21-25, 2024. We apologize for any inconvenience caused by this issue. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-04-29 | French | Compare |
v3 | 2024-04-29 | English | Compare |
v2 | 2024-04-22 | French | Compare |
v1 | 2024-04-22 | English | Compare |
Showing 1 to 4 of 4